Ming Zhou

Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer

Shun Lü, Wei Zhang, Lin Wu et al. · JAMA · 2024 · 336 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With <i>EGFR</i> Variant

Wen‐Feng Fang, Yuanyuan Zhao, Yongzhong Luo et al. · JAMA · 2024 · 168 citations · Full text

Medicine, Oncology, Pharmacology +16

Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China

Anwen Xiong, Lei Wang, Jianhua Chen et al. · The Lancet · 2025 · 133 citations

Medicine, Oncology, Pharmacology +13

AK112, a novel PD-1/VEGF bispecific antibody, in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC): an open-label, multicenter, phase II trial

Yuanyuan Zhao, Gang Chen, Jianhua Chen et al. · EClinicalMedicine · 2023 · 98 citations · Full text

Medicine, Oncology, Pharmacology +17

Neoadjuvant Osimertinib for Resectable <i>EGFR</i> -Mutated Non–Small Cell Lung Cancer

Jianxing He, Masahiro Tsuboi, Walter Weder et al. · Journal of Clinical Oncology · 2025 · 61 citations · Full text

Medicine, Oncology, Pharmacotherapy +17